Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Accept all cookies Reject all non-essential cookies

Search results

Found 2787 matches for

The Oxford Safer Pregnancy Alliance [OSPREA] and the Oxford Vaccine Group [OVG] have recently undertaken a successful recruitment drive for a study of maternal immunisation to prevent infant Respiratory Syncytial Virus [RSV] infection.

Sir Andrew Pollard

Sir Andrew Pollard

BSc MBBS PhD (Lond), DIC, MRCP (UK), FHEA, FRCPCH, MA, FMedSci, FRS Sir Andrew Pollard - Ashall Professor of Infection & Immunity

Emma Francis

Emma Francis

Emma Francis - Research Practitioner

Rinn Song

Rinn Song

Rinn Song - Clinical Scientist

Hannah Roberts

Hannah Roberts

Hannah Roberts - Senior Research Nurse

Rachel Anslow

Rachel Anslow

Rachel Anslow - Senior Research Assistant

Olga Mazur

Olga Mazur

Olga Mazur - Senior Data Manager

Karen Ford

Karen Ford

Karen Ford - Immunisation Specialist / Senior Research Nurse

Amber Thompson

Amber Thompson

Amber Thompson - Senior QA and Sample Compliance Manager

Sonu Shrestha

Sonu Shrestha

Sonu Shrestha - Research Assistant

Dominic Kelly

Dominic Kelly

Dominic Kelly - BRC Consultant in Paediatrics and Vaccinology.

Emma Plested

Emma Plested

Emma Plested - Programme and Regulatory Affairs Director (UK)

Hannah Robinson

Hannah Robinson

Hannah Robinson - Clinical Operations Director

Parvinder Aley

Parvinder Aley

OBE, PhD Parvinder Aley - Director of Global Operations (OVG)

Samantha Vanderslott

Samantha Vanderslott

Samantha Vanderslott - Associate Professor

Daniel O'Connor

Daniel O'Connor

BSc AFHEA MSc DPhil (OXON) Daniel O'Connor - Associate Professor | Head of Bioinformatics

Elizabeth Clutterbuck

Elizabeth Clutterbuck

Elizabeth Clutterbuck - Researcher

Elizabeth Jones

Elizabeth Jones

Elizabeth Jones - Research Assistant

Sagida Bibi

Sagida Bibi

PhD Sagida Bibi - Postdoctoral Research Assistant

Susana Camara

Susana Camara

PhD, DVM Susana Camara - Post-Doc Researcher

Yama G.Farooq

Yama G.Farooq

BCA Computer Application , MSc in Information Technology and Software Engineering Yama G.Farooq - Programming and Data Management Director

Load More

Similar stories

Oxford vaccine against deadly Nipah virus granted EMA PRIME designation for the first time

The University of Oxford’s vaccine to protect people from deadly Nipah virus has been granted support from the PRIority MEdicines (PRIME) scheme offered by Europe’s medicines regulator, the European Medicines Agency (EMA). It is the first UK academic institution to be awarded this designation.

New MenB Vaccine Shows Promise in Early-Stage Trial Results

Study shows urgent change needed to reduce deaths from malaria and meningitis in comatose African children

Oxford Vaccine Group Launches Novel Study on Relapsing Malaria

Oxford Vaccine Group Launches Study to Test Paratyphoid A Vaccine

Typhoid vaccine trial confirms sustained protection for older children